Website: http://www.therasim.com
Similar Companies:
Acacia Pharma
United Kingdom
Publicly Traded
Acacia is building a sustainable, hospital based pharmaceutical business based on products targeting the secondary care market in oncology and peri-operative care. The company initiated product development programs in cachexia and post-operative nausea and vomiting. The cancer secondary care market provides a large and growing market opportunity that consists of existing and new supportive care indications.
Seres Therapeutics
USA
Privately Held
Seres Health is a clinical stage biotherapeutic company focused on discovering and developing Ecobiotic® therapeutic products to treat important diseases by targeting the underlying biology of the human microbiome. Seres is pioneering the first therapeutics that catalyze a shift to health by augmenting the biology of the microbiome. Current candidates span metabolic, inflammatory, and infectious diseases.
Neos Therapeutic
USA
Acquired/Merged (Assumed)
Neos Therapeutics, Inc. is a commercial-stage pharmaceutical company developing and manufacturing central nervous system (CNS)-focused products. Neos markets Adzenys XR-ODT® (amphetamine) extended-release orally disintegrating tablets (see Full Prescribing Information, including Boxed WARNING), Cotempla XR-ODT® (methylphenidate) extended-release orally disintegrating tablets (see Full Prescribing Information, including Boxed WARNING), and Adzenys-ER® (amphetamine) extended-release oral suspension (see Full Prescribing Information, including Boxed WARNING), all for the treatment of ADHD. Neos also has a development candidate, NT0502, for the treatment of sialorrhea in patients with neurological conditions.
Macrolide Pharmaceuticals
USA
Privately Held
Macrolide Pharmaceuticals is a next-generation antibiotics company developing macrolides that are first-in-class with Gram-negative activity and will have broad applicability across multiple resistant infectious diseases. The company was founded in 2015 with a fully-synthetic technology platform licensed from Harvard University. The platform is a groundbreaking technological advance that holds the foundational key to discover and create new macrolides from basic chemical building blocks that transform this class from its traditional Gram-positive spectrum to include multi-drug resistant (MDR) Gram-negative pathogens. Macrolide is supported and advised by world-class investors, partners, Board members, scientific advisors and funding organizations. Its lead program aims to address MDR infections caused by Gram-negative pathogens.
Vestagen
USA
Privately Held
Vestagen develops advanced performance textile products and technologies including VESTEX, which represents a new class of Active Barrier protective fabrics combining antimicrobial, liquid repellent and breathability properties. VESTEX fabric is designed to protect the uniforms and apparel healthcare workers and their patients wear.
CoheroHealth
USA
Acquired/Merged
Cohero Health is a digital health company developing innovative tools and technologies to improve respiratory care, reduce avoidable costs, and optimize medication utilization. The company's connected devices and mobile applications actively engage and empower respiratory patients by measuring lung function and tracking adherence.